BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15751046)

  • 1. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.
    Haferlach T; Kohlmann A; Schnittger S; Dugas M; Hiddemann W; Kern W; Schoch C
    Genes Chromosomes Cancer; 2005 Jun; 43(2):113-27. PubMed ID: 15751046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
    Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
    Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status.
    Marasca R; Maffei R; Zucchini P; Castelli I; Saviola A; Martinelli S; Ferrari A; Fontana M; Ravanetti S; Torelli G
    Leukemia; 2006 Jan; 20(1):103-14. PubMed ID: 16270043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.
    Debernardi S; Lillington DM; Chaplin T; Tomlinson S; Amess J; Rohatiner A; Lister TA; Young BD
    Genes Chromosomes Cancer; 2003 Jun; 37(2):149-58. PubMed ID: 12696063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
    Piedras J; López-Karpovitch X; Cárdenas R
    Cytometry; 1998 Aug; 32(4):286-90. PubMed ID: 9701397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of acute leukemias by use of microarray technology.
    Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2003 Aug; 37(4):396-405. PubMed ID: 12800151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
    Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
    Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptic t(15;17) in a patient with AML M3 and a complex karyotype.
    Göhring G; Lange K; Atta J; Krauter J; Hölzer D; Schlegelberger B
    Cancer Genet Cytogenet; 2007 May; 175(1):77-80. PubMed ID: 17498564
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of gene expression signatures for molecular classification in human leukemia cells.
    Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
    Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
    García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
    Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
    Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
    Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
    Heuser M; Wingen LU; Steinemann D; Cario G; von Neuhoff N; Tauscher M; Bullinger L; Krauter J; Heil G; Döhner H; Schlegelberger B; Ganser A
    Haematologica; 2005 Nov; 90(11):1484-92. PubMed ID: 16266895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases.
    De Rossi G; Avvisati G; Coluzzi S; Fenu S; LoCoco F; Lopez M; Nanni M; Pasqualetti D; Mandelli F
    Eur J Haematol; 1990 Sep; 45(3):168-71. PubMed ID: 1977611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
    Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
    Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups.
    Schoch C; Kohlmann A; Dugas M; Kern W; Schnittger S; Haferlach T
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1164-8. PubMed ID: 17001623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.